Call for Abstracts

Abstract Submission Deadline

Abstract Submission deadline is now passed.
Thank you for submitting your abstract for JSV 2021.

May 10th (Mon)~July 30th (Fri)
Extended until August 16th (Mon)

* The mini-symposium will be selected from the abstracts registered for free paper oral presentations (in person).

* Outstanding Poster Presentation Award will be selected from poster presentations (poster presentation abstract registration).

Eligibility

To submit an abstract, the following criteria must be met :

  • Those who wish to submit abstracts for this meeting must complete your registration before the abstract submission.
    If you have not registered yet, please visit the Online Registration page first.
  • The first and presenting author must be a member of the Japanese Society for Virology (JSV). Nonmembers who wish to submit abstracts should join JSV first.
  • The JSV membership number is required when you submit an abstract.
    Please put 0079999999 if you are in the process of joining JSV members.
  • JSV membership is not necessarily required for those who belong to overseas facilities.
  • International students in Japan should join JSV membership if they wish to submit abstracts.
  • Join JSV membership through the website of The Japanese Society for Virology.
Inquiry about JSV membership
The Japanese Society for Virology
c/o Microbiological Science, Inc.
4-13-18 Koishikawa, Bunkyo-ku, Tokyo 112-0002, Japan
E-mail:biseibutsu-com@umin.ac.jp

Guideline for Abstract Submission

1. Presentation Style/Language

Presentation language and the abstract text must be the same language.

Presentation Style Abstract Title(*) Abstract Text Authors(*) Affiliations(*)
Oral English English English English
Poster English English English English

* Japanese authors are requested to put both Japanese and English.

2. How to submit an abstract

  • All abstract submissions must be made electronically through the online abstract submission system, Confit.
    *Abstracts should not be submitted by post or e-mail.
    *Browser to be used are;

    •Microsoft Edge (latest version) / •Internet Explorer (latest version)
    •Firefox (latest version) / •Safari (latest version) / •Chrome (latest version)

  • Abstract text should be structured as follows: Objectives - Methods - Results - Discussion.
  • Abstract title and text are within140 characters, and 2,000 characters reservedly.
  • Please retain your login ID and  password (you set your own login ID whithin 32 characters, and password between 8 and 32 characters long).
    For security reasons, the secretariat is not arrowed to respond to inquiries concerning ID and passwords.

3. Abstract Category

For each category (A, B, and C), please select the one most suitable topics for your presentation.

[A]
A01 Plant viruses
A02 Insect viruses
A03 Adenoviridae
A04 Herpesviridae
A05 Arenaviridae
A06 Astroviridae
A07 Asfarviridae
A08 Rhabdoviridae
A09 Bornaviridae
A10-1 Hantaviridae
A10-2 Phenuiviridae
A10-3 Nairoviridae
A11 Caliciviridae
A12 Coronaviridae (except for
SARS-CoV-2)
A13 Coronaviridae (SARS-CoV-2)
A14 Filoviridae
A15 Flaviviridae(Except for Hepacivirus)
A16 Flaviviridae (Hepacivirus)
A17 Togaviridae
A18 Hepadnaviridae
A19 Hepeviridae
A20 Orthomyxoviridae
A21 Papillomaviridae
A22 Paramyxoviridae
A23 Parvoviridae
A24 Picornaviridae
A25 Polyomaviridae
A26 Poxviridae
A27 Reoviridae
A28 Retroviridae (Lentivirus)
A29 Retroviridae (except for Lentivirus)
A30 Prion
A31 Viroid
A32 Phage
A33 Others
[B]
B01 Structure
B02 Virus entry
B03 Genome and gene expression
B04 Assembly and release
B05 Replication of genome
B06 Viral spread and transmission
B07 Pathogenesis
B08 Oncogenesis
B09 Epidemiology
B10 Diversity and evolution
B11 Immunity
B12 Vaccines
B13 Antivirals
B14 Gene therapy and viral vectors
B15 Data analysis and mathematical model
B16 Others

4. Notice

  • It is not permitted to present the same abstract at a scientific meeting as the one already published in scientific journals.
  • One abstract will be accepted per presenter (first author).
  • Co-authors are eligible to submit more than one abstract.
  • Only one abstract will be accepted when the abstracts from the same group are obviously considered as one presentation.
  • Please include the latest research result.
  • The following abstracts will not be accepted: aim of study is not clear, irrelevant replication research, containing significant errors, gap between experiment and conclusion, and lack in moral consideration, etc.
Acceptance Notice
  • The program committee is responsible for reviewing all abstracts and deciding presentation style and time. If you have not received an e-mail notification, please contact the meeting secretariat.
  • Notification regarding acceptance or rejection will be sent to the submitting authors’e-mail address by the end of August, 2020.
Online Abstract Submission

Enquires

Please contact the Abstract Office if you have any enquiries related to the abstract submission.

Abstract Office
KYODOPLUS CORPORATION
Add: 2346-1 Senoo, Minami-ku, Okayama, 701-0205 JAPAN
E-mail:jsv68@kwcs.jp

TOP